Insider · CIK 0001378656

O'Keeffe Charles B

Reports to the SEC for 1 company · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001378656

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	732,470
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	208,274
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	728,470
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	212,274
2024-12-10	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$4.01	+$160K	727,137
2024-12-10	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	213,607
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	687,137
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	253,607
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+23.2K sh	—	—	252,179
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,841 sh	—	—	255,020
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	685,724
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	228,931
2024-01-02	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+60K sh	$1.13	+$67.8K	681,724
2024-01-02	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−60K sh	—	—	232,931
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	621,724
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	292,931
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+29.5K sh	—	—	290,024
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+4,240 sh	—	—	294,264
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	620,391
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	260,500
2023-01-24	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$0.79	+$39.5K	616,391
2023-01-24	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	264,500
2022-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+15K sh	—	—	310,500
2022-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+4,000 sh	—	—	314,500
2022-12-06	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,334 sh	—	—	566,391
2022-12-06	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,334 sh	—	—	295,500
2022-11-15	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director	SSale	+88K sh	$16.04	+$1.41M	565,057
2022-08-18	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$2.53	+$101K	653,042
2022-08-18	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	296,834
2022-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+12K sh	—	—	336,834
2021-12-28	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+20K sh	—	—	324,834
2021-12-03	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	613,042
2021-12-03	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	304,834
2021-08-16	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$3.12	+$156K	611,709
2021-08-16	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	306,167
2020-12-30	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+30K sh	—	—	356,167
2020-12-22	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	561,709
2020-12-22	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,333 sh	—	—	326,167
2020-09-30	CPRXCATALYST PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+7,000 sh	$2.99	+$20.9K	560,376
2019-12-02	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+33.5K sh	—	—	323,500
2019-12-02	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	327,500
2019-10-11	CPRXCATALYST PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+10K sh	$4.70	+$47K	553,376
2018-12-19	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+25K sh	—	—	265,000
2018-12-19	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+25K sh	—	—	290,000
2018-12-14	CPRXCATALYST PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+20K sh	$2.50	+$50K	543,376
2018-06-07	CPRXCATALYST PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+1,000 sh	$3.35	+$3,352.3	523,376
2018-06-07	CPRXCATALYST PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+4,000 sh	$3.31	+$13.2K	522,376
2018-06-01	CPRXCATALYST PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+5,000 sh	$3.74	+$18.7K	518,376
2018-01-02	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+20K sh	—	—	220,000
2018-01-02	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+20K sh	—	—	240,000

Recent filings

Accepted (ET)
Feb 194
O'Keeffe Charles B0001161697-25-000071
SEC(opens sec.gov)
Dec 314
O'Keeffe Charles B0001161697-24-000543
SEC(opens sec.gov)
Dec 114
O'Keeffe Charles B0001161697-24-000506
SEC(opens sec.gov)
Nov 254
O'Keeffe Charles B0001161697-24-000481
SEC(opens sec.gov)
Feb 164
O'Keeffe Charles B0001161697-24-000104
SEC(opens sec.gov)
Jan 34
O'Keeffe Charles B0001161697-24-000026
SEC(opens sec.gov)
Dec 294
O'Keeffe Charles B0001161697-23-000651
SEC(opens sec.gov)
Dec 124
O'Keeffe Charles B0001161697-23-000615
SEC(opens sec.gov)
Feb 174
O'Keeffe Charles B0001161697-23-000133
SEC(opens sec.gov)

Companies

CATALYST PHARMACEUTICALS, INC.DirectorCPRX

Address

355 ALHAMBRA CIRCLE, SUITE 1370

CORAL GABLES, FL, 33134